abrdn World Healthcare Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2015-06-26. abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt securities of public and private United States and non-United States companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, healthcare distributors, and others. The Fund’s investment adviser is abrdn Inc.
根据最新的财务报表(Form-10K),abrdn World Healthcare Fund 的总资产为 $637,净利润为 $55
THW 的关键财务比率是什么?
abrdn World Healthcare Fund 的流动比率是 5.13,净利 margin 为 500,每股销售为 $0.27。
abrdn World Healthcare Fund 的收入按细分市场或地理位置如何划分?
abrdn World Healthcare Fund 最大收入来源是 Banking and Related Activities,在最近的收益报告中收入为 42,273,170。就地区而言, United States 是 abrdn World Healthcare Fund 的主要市场,收入为 42,273,170。
abrdn World Healthcare Fund 是否盈利?
是的,根据最新的财务报表,abrdn World Healthcare Fund 的净利润为 $55